NHS Framework Agreement for Proprietary Pharmaceuticals - South of England (Tranche A)
key details
| Value | £232,000,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | South East, South West |
| Deadline | 29 Jun 2017 |
| Contract start | 1 Sept 2017 |
| Contract end | 31 Aug 2021 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-9426953f-bc8d-40a0-be59-e8558ece1905 |
Awards (22)
This procurement was awarded to 22 suppliers. Values shown are per-award; the notice total is £232,000,000.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Abbvie Ltd shared | £232,000,000 | 10 Aug 2017 | active |
| ACTAVIS UK Ltd shared | £232,000,000 | 10 Aug 2017 | active |
| Allergan UK limited shared | £232,000,000 | 10 Aug 2017 | active |
| Amgen Ltd. shared | £232,000,000 | 10 Aug 2017 | active |
| Bristol-Myers Squibb Pharmaceuticals Ltd. shared | £232,000,000 | 10 Aug 2017 | active |
| Chugai Pharma UK Ltd shared | £232,000,000 | 10 Aug 2017 | active |
| Eli Lilly & Company Limited shared | £232,000,000 | 10 Aug 2017 | active |
| Ferring Pharmaceutical shared | £232,000,000 | 10 Aug 2017 | active |
| Gilead Sciences Ltd shared | £232,000,000 | 10 Aug 2017 | active |
| Ipsen Limited shared | £232,000,000 | 10 Aug 2017 | active |
| Janssen-Cilag Ltd shared | £232,000,000 | 10 Aug 2017 | active |
| Merck Serono shared | £232,000,000 | 10 Aug 2017 | active |
| Merck Sharp & Dohme (MSD) shared | £232,000,000 | 10 Aug 2017 | active |
| Merz Pharma UK Ltd shared | £232,000,000 | 10 Aug 2017 | active |
| Novo Nordisk Ltd shared | £232,000,000 | 10 Aug 2017 | active |
| Pfizer Limited shared | £232,000,000 | 10 Aug 2017 | active |
| Pharmacosmos UK Ltd. shared | £232,000,000 | 10 Aug 2017 | active |
| Roche Products Ltd shared | £232,000,000 | 10 Aug 2017 | active |
| Sandoz Limited shared | £232,000,000 | 10 Aug 2017 | active |
| Teva UK Limited shared | £232,000,000 | 10 Aug 2017 | active |
| Vifor Pharma UK Limited shared | £232,000,000 | 10 Aug 2017 | active |
| ViiV Healthcare Limited shared | £232,000,000 | 10 Aug 2017 | active |
description
An open procurement exercise has been conducted to supply proprietary pharmaceuticals to participatingsecondary care trusts in the South of England.
Whilst this framework agreement is intended for use by the NHS in England. The framework may also be usedby private sector contractors and agents working on behalf of the NHS in England.
Additional information:
Note regarding publication of the resulting framework agreement:
| - | The template framework agreement has been published as an attachment to this notice; |
| - | Redacted award schedules (i.e. schedule 6) have been included for each successful supplier. |
For ease of undersatnding the temaplate framework aggreement has been attached.
An award shedlue for each sussfull has been attached
documents
- https://www.contractsfinder.service.gov.uk/Notice/8a3b2ff0-6c7e-402f-940b-2cbbe4984864 , tenderNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 18 Sept 2017 | Award (award) | · | 7bebd720-62b8-4f28-b544-1d8deaeee34d-171205 |
more from NHS England
- Urgent Award - haematological screening · £16,202 · 29 Jul 2026
- HSCN-AWS Connectivity Service for Spine · £228,060 · 29 Jul 2026
- Incentive Voucher Provider · £60,000 · 29 Jul 2026
- CRM for NHSE participant/candidate data 26-27 · £56,640 · 28 Jul 2026
- Wayfinder and First Contact Digital Clinical Support 2026-27 · £748,000 · 23 Jul 2026
- Support Services for PPM application · £860,000 · 22 Jul 2026
- Digital Maturity Assessment · 21 Jul 2026
- Integrated Healthcare Services to Haslar Immigration Removal Centre (IRC) · £19,052,186 · 13 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.